Skip to main content

Synergus

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
    • Subscribe to Synergus RWE News
    • IGES group
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Hands-on market access support
      • Reimbursement dossier / HTA dossier
      • Reimbursement/DRG analysis
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Subscribe to Synergus RWE News
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Reimbursement/DRG analysis
      • Reimbursement dossier / HTA dossier
      • Hands-on market access support
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

Blog

Finnish Real World-World data sources – National registries
05 Oct 2022

Tags:
HQ_RWDFinlandReal World Data
read more
Swedish Real-World data sources – National registries
08 Sep 2022

Tags:
HQ_RWDSwedenReal World Data
read more
High quality RWE - Registry based randomized clinical trials
31 Aug 2022

Tags:
Real World EvidenceSwedenHQRWE_FractureR-RCT
read more
High-quality RWE – Transparency about data quality
10 Aug 2022

Tags:
Real World EvidenceSwedenHQRWE_Fracture
read more
Reimbursement may not be the primary barrier for digital health!?
04 Mar 2022

Tags:
Digital HealthGermanyDHS Germany
read more
The German NUB process, the most risky process for a start-up?
08 Feb 2022

Tags:
GermanyCoverage with Evidence DevelopmentInnovation Funding
read more
The best real-world data setting for diabetes research – How much data is required?
21 Jan 2022

The Swedish setting provides an extremely rich data set with very high quality for diabetes research.

Tags:
DiabetesReal World EvidenceReal World DataHQ_RWD
read more
Pharma blog
20 Dec 2020

More pharma blog's will come.

Tags:
Pharma
read more
Five digital solutions approved for temporary reimbursement in Germany – Up to 2000 €/year in reimbursement
09 Nov 2020

Tags:
Digital HealthGermanyDHS Germany
read more
Do we know what the problem is that we are trying to solve regarding the COVID-19 Pandemic?
27 Mar 2020

Tags:
COVID-19
read more
  • Show More

Contact us

Tags

Alzheimer
Artificial Intelligence
Breast cancer
China
Co-payment
Corona virus
Country specific
Coverage with Evidence Development
COVID-19
Data Science in Oncology
Dementia
Denmark
DHS Belgium
DHS France
DHS Germany
Diabetes
Digital Health
Digital Heath Strategies
Disease Specific
EMA
Empowered Patients
EQ-5D
EU HTAR
EU HTAR IVD
EU HTAR Medtech
Finland
France
Funding
Germany
Health Economics
Heart Failure
HQRWE_Fracture
HQ_RWD
HTA
Imaging
Innovation Funding
Italy
IVD
Legislation
Lung Cancer
Market Access
Medical Device
Melanoma
Mental Health
Multiple Sclerosis
Myeloma
Netherlands
Norway
Obesity
Oncology
Out-patient procedures
Patient Registries
Pharma
Quality of Life
R-RCT
Real World Data
Real World Evidence
RefugeeMD
Registries
Rheumatoid Arthritis
RWD Scientific Impact
RWD_DK
SF-36
Stroke
Sweden
The Netherlands
Throat Cancer
Transferability of Outcomes
United Kingdom
Value Based Healthcare
  • Home
  • About
  • RWE impact
  • Market Access
  • HEOR
  • Events/Webinars
  • News
  • Blog